[EN] SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF<br/>[FR] SPIRO-LACTAME MODULATEUR DE RÉCEPTEURS NMDA ET LEURS UTILISATIONS
申请人:APTINYX INC
公开号:WO2019152688A1
公开(公告)日:2019-08-08
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders as well as other disorders.
披露了在调节NMDA受体活性方面具有潜力的化合物。这些化合物可用于治疗抑郁症和相关疾病以及其他疾病。